Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C8H9NO2 |
| Molecular Weight | 151.1626 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](C(O)=O)C1=CC=CC=C1
InChI
InChIKey=ZGUNAGUHMKGQNY-SSDOTTSWSA-N
InChI=1S/C8H9NO2/c9-7(8(10)11)6-4-2-1-3-5-6/h1-5,7H,9H2,(H,10,11)/t7-/m1/s1
| Molecular Formula | C8H9NO2 |
| Molecular Weight | 151.1626 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL4676 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16380257 |
30.0 µM [Ki] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:25 GMT 2025
by
admin
on
Mon Mar 31 18:10:25 GMT 2025
|
| Record UNII |
GF5LYS471N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50889362
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | |||
|
GF5LYS471N
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | |||
|
875-74-1
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | |||
|
70134
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | |||
|
212-876-3
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | |||
|
44962
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | |||
|
m8672
Created by
admin on Mon Mar 31 18:10:25 GMT 2025 , Edited by admin on Mon Mar 31 18:10:25 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
|
PARENT -> IMPURITY |
|
||
|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
|